SOCIALVACCINES

Social Vaccination in Ant Colonies: from Individual Mechanisms to Society Effects

 Coordinatore Institute of Science and Technology Austria 

Spiacenti, non ci sono informazioni su questo coordinatore. Contattare Fabio per maggiori infomrazioni, grazie.

 Nazionalità Coordinatore Austria [AT]
 Totale costo 1˙299˙780 €
 EC contributo 1˙299˙780 €
 Programma FP7-IDEAS-ERC
Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call ERC-2009-StG
 Funding Scheme ERC-SG
 Anno di inizio 2010
 Periodo (anno-mese-giorno) 2010-04-01   -   2015-03-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    UNIVERSITAET REGENSBURG

 Organization address address: UNIVERSITAETSSTRASSE 31
city: REGENSBURG
postcode: 93053

contact info
Titolo: Dr.
Nome: Christian
Cognome: Blomeyer
Email: send email
Telefono: -4144
Fax: -3380

DE (REGENSBURG) beneficiary 21˙540.00
2    Institute of Science and Technology Austria

 Organization address address: Am Campus 1
city: Klosterneuburg
postcode: 3400

contact info
Titolo: Dr.
Nome: Sylvia Maria
Cognome: Cremer-Sixt
Email: send email
Telefono: +43 2243 9000
Fax: +43 2243 9000 2000

AT (Klosterneuburg) hostInstitution 1˙278˙240.00
3    Institute of Science and Technology Austria

 Organization address address: Am Campus 1
city: Klosterneuburg
postcode: 3400

contact info
Titolo: Ms.
Nome: Barbara
Cognome: Abraham
Email: send email
Telefono: +43 2243 9000 1020
Fax: +43 2243 9000 2000

AT (Klosterneuburg) hostInstitution 1˙278˙240.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

infection    vaccinated    anti    protein    phd    physiological    colony    disease    infected    defences    members    social    vaccination    ants    collective    spread    parasite    individual    healthy    immune    group    individuals   

 Obiettivo del progetto (Objective)

'Living in social groups leads to a high risk of disease spread. Insect societies counteracted this threat by evolving sophisticated collective anti-parasite defences, combining the immune systems of all group members and their collective social hygienic behaviours. I recently described a direct link between these social and individual defences, by showing that social contact to an infected individual results in a protective Social Vaccination in its nestmate ants: the latter survived an infection with the same pathogen significantly better than control ants that had lived with other healthy ants only. Aim of this project is to elucidate the molecular and physiological mechanisms of this Social Vaccination in individual ants, and its effect on the organisation of collective defences and disease dynamics at the colony level. Preliminary results have shown different protein upregulation in healthy, infected and vaccinated ants, and a detailed analysis of gene and protein expression patterns will define those proteins and their function in anti-parasite defence (postdoc). Observations of the social interactions between infected ants and their group members, and measures of the physiological immune responses of the individuals at different stages of the infection and after the vaccination will further reveal when and how Social Vaccination occurs, how long it endures, and how specific and plastic it is (PhD 1). At the colony level, the social role of vaccinated individuals and the fate of infected ants when loosing their vaccination potential will be determined, as well as the effects of Social Vaccination on disease spread in the colony and the regulation of collective defences between group members (PhD 2). This unique combination studying both the social and individual aspect of immune defences makes this project valuable for the fields of Social Evolution and Ecological Immunology, and further impacts on Epidemiology, Evolutionary Medicine and Biocontrol.'

Altri progetti dello stesso programma (FP7-IDEAS-ERC)

BP-CARDIO (2013)

"Investigating the therapeutic potential of manipulating the IGF-IGFBP1 axis in the prevention and treatment of cardiovascular disease, diabetes and obesity."

Read More  

A SMILE (2014)

analyse Soluble + Membrane complexes with Improved LILBID Experiments

Read More  

CHROMOTHRIPSIS (2014)

Dissecting the Molecular Mechanism of Catastrophic DNA Rearrangement in Cancer

Read More